PERCUTANEOUS LEADS WITH LATERALLY DISPLACEABLE PORTIONS, AND ASSOCIATED SYSTEMS AND METHODS
Percutaneous leads with laterally displaceable sections, and associated systems and methods are disclosed. A device in accordance with a particular embodiment includes a lead body that in turn includes first, second and third percutaneous portions. The first portion can carry an electrical contact, the second portion can be spaced apart from the first portion, and the third portion can be positioned between the first and second portions along a deployment axis. The third portion can have a stiffness in a direction transverse to the deployment axis that is less than a stiffness of both the first and second portions transverse to the deployment axis, and a diameter that is less than corresponding diameters of the first and second portions.
Latest Nevro Corporation Patents:
- MRI compatible medical devices
- Systems and methods for selecting low-power, effective signal delivery parameters for an implanted pulse generator
- Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods
- Implanted pulse generators with reduced power consumption via signal strength/duration characteristics, and associated systems and methods
- Linked area parameter adjustment for spinal cord stimulation and associated systems and methods
The present disclosure is directed generally to percutaneous leads with laterally displaceable portions, and associated systems and methods.
BACKGROUNDNeurological stimulators have been developed to treat pain, movement disorders, functional disorders, spasticity, cancer, cardiac disorders, and several other medical conditions. Implantable neurological stimulation systems generally have an implantable pulse generator and one or more electrode leads that deliver electrical pulses to neurological tissue or muscle tissue. For example, several neurological stimulation systems for spinal cord stimulation (SCS) have cylindrical leads that include a lead body with a circular cross-sectional shape and one or more conductive rings spaced apart from each other at the distal end of the lead body. The conductive rings operate as individual electrodes. In many cases, the SCS leads are implanted percutaneously through a large needle inserted into the epidural space, with or without the assistance of a stylet. One concern of such leads is that the leads may not remain in the desired position after being implanted. This is undesirable because, if the leads migrate from the initial implantation site, the stimulation provided by the electrodes may no longer be directed to the appropriate target tissue. Accordingly, the efficacy of the treatment can be significantly compromised.
Another type of stimulation lead is a paddle lead. Paddle leads typically have a relatively flat body with electrodes arranged on one side of the body. Paddle leads are commonly used for cortical stimulation and SCS applications. Large paddle leads are desirable because they cover more neurological structures and, in at least some cases, may be more stable and less subject to migration than cylindrical leads. However, large paddle leads are not well suited to percutaneous implantation. As a result, large paddle leads are often surgically implanted using highly invasive procedures that are costly and can lead to patient complications.
One approach to addressing the potential for lead migration is to provide structural reinforcement in one or more portions of the lead, as disclosed in U.S. Pat. No. 7,146,222. However, this approach is principally directed to brain implants, and may not be effective for implantation at other sites, including the spinal cord. Accordingly, there remains a need for improved stimulation devices that resist migration.
Specific details of several embodiments of the disclosure are described below with reference to implantable leads for stimulating neural structures, methods for implanting leads, and methods for stimulating a target neural site of a patient. Although selected embodiments are described below with respect to stimulating the dorsal root and/or other regions of the spinal column to control pain, the leads may in some instances be used for stimulating other neurological structures, and/or other tissue (e.g., muscle tissue). Several embodiments can have configurations, components or procedures different than those described in this section, and other embodiments may eliminate particular components or procedures. A person of ordinary skill in the relevant art, therefore, will understand that the invention may have other embodiments with additional elements, and/or may have other embodiments without several of the features shown and described below with reference to
A patient treatment device in accordance with a particular embodiment includes a lead body having three percutaneous portions. The percutaneous portions include a first portion carrying an electrode and having a first diameter, a second portion spaced apart from the first portion and having a second diameter, and a third portion positioned between the first and second portions along a deployment axis. The third portion has a third diameter less than the first and second diameters, and a stiffness in a direction transverse to the deployment axis that is less than the stiffness of the first portion transverse to the deployment axis, and less than a stiffness of the second portion transverse to the deployment axis. Accordingly, in particular embodiments, the reduced diameter and reduced stiffness of the intermediate third portion can provide strain relief and reduces the likelihood that the first portion, which is typically located at or near the stimulation site, will become displaced from the stimulation site. For example, the intermediate portion can allow relative movement between the first portion located at the stimulation site, and the second portion, which may be spaced apart from the stimulation site. Such relative movement can occur when the patient moves (e.g., bends or twists) in a certain manner.
In particular embodiments, the third portion includes a flexible, electrical link that is coupled to the electrode and is unsupported between the first and second portions in a direction transverse to the deployment axis. The electrical link can include, for example, an insulated wire or a ribbon of insulated wires. In some cases, the third portion also includes an axial reinforcing fiber arranged along the wire(s).
In still another particular arrangement, the lead body includes a first axial aperture extending into the first portion, and a second axial aperture extending through the second portion. The delivery device can include a stylet that is removably received in both the first and second apertures. The first portion and the stylet can be releaseably coupled to each other with a bayonet fitting, and can be separated from each other via relative twisting and axial movement of the stylet relative to the first portion.
Further aspects of the disclosure are directed to methods for deploying a treatment device. A representative method includes delivering a lead body into a patient's body so that a first portion of the lead body having a first diameter and carrying an electrode is proximate to a spinal stimulation site, a second portion of the lead body having a second diameter is positioned radially outwardly from the first portion, and a third portion of the lead body is positioned between the first and second portions. The third portion can have a third diameter less than both the first and second diameters. The method can further include at least partially fixing the first portion, the second portion, or both the first and second portions to the patient's body, while allowing the third portion to accommodate relative movement between the first and second portions.
In particular embodiments, the first portion of the lead body can be positioned within the spinal canal, and the second portion of the lead body can be positioned external to the spinal canal. The electrode carried by the first portion can be located in electrical communication with dorsal root neurons, in a gutter along the spinal cord, or in a dorsal root entry zone.
B. Overview of Embodiments of Implantable Neural Stimulation Systems and Associated MethodsThe pulse generator 101 can transmit signals to the lead body 110 that up-regulate (e.g. stimulate) and/or down-regulate (e.g. block) target nerves. Accordingly, the pulse generator 101 can include a machine- (e.g., computer-) readable medium containing instructions for generating and transmitting suitable therapy signals. The pulse generator 101 and/or other elements of the system 100 can include one or more processors, memories and/or input/output devices. The pulse generator 101 can include multiple portions, e.g., for directing signals in accordance with multiple signal delivery parameters, housed in a single housing (as shown in
In some embodiments, the pulse generator 101 can obtain power to generate the therapy signals from an external power source 103. The external power source 103 can transmit power to the implanted pulse generator 101 using electromagnetic induction (e.g., RF signals). For example, the external power source 103 can include an external coil 104 that communicates with a corresponding internal coil (not shown) within the implantable pulse generator 101. The external power source 103 can be portable for ease of use.
In another embodiment, the pulse generator 101 can obtain the power to generate therapy signals from an internal power source, in addition to or in lieu of the external power source 103. For example, the implanted pulse generator 101 can include a non-rechargeable battery or a rechargeable battery to provide such power. When the internal power source includes a rechargeable battery, the external power source 103 can be used to recharge the battery. The external power source 103 can in turn be recharged from a suitable power source (e.g., conventional wall power).
In still further embodiments, an external programmer (not shown) can communicate with the implantable pulse generator 101 via electromagnetic induction. Accordingly, a practitioner can update the therapy instructions provided by the pulse generator 101. Optionally, the patient may also have control over at least some therapy functions, e.g., starting and/or stopping the pulse generator 101.
The first portion 111a can include signal delivery electrodes 112 that have an annular or ring shape and are exposed at the outer circumferential surface of the first portion 111a, as shown in
The second portion 111b can include the connection terminals 113 described above, and can have an overall diameter D2. In a particular embodiment, the diameter D2 of the second portion of 111b can be approximately the same as the diameter D1 of the first portion of 111a. The second portion 111b can include a second fixation device 115b, for example, one or more sutures 106 that secure or at least partially secure the second portion 111b in position. Each of the first and second portions 111a, 111b can include rounded, convex external surfaces 105 (e.g., at the proximal end of the first portion 111a and/or at the distal end of the second portion 111b) that are exposed to patient tissue and, due to the rounded shapes of these surfaces, facilitate moving the lead body 110 in the patient's body.
The first portion 111a, the second portion 111b, and the third portion 111c can be arranged along a deployment axis A. The electrical link 108 can include one or more wires 114 connected between the signal delivery electrodes 112 at the first portion 111a and the connection terminals 113 at the second portion 111b. In an embodiment shown in
In a particular embodiment, the third portion 111c has a diameter D3 that is less than the diameter D1 of the first portion 111a, and/or less than the diameter D2 of the second portion 111b. As shown in cross section in
In operation, the catheter 120 is positioned percutaneously within the patient, and the delivery device 130 is used to push the lead body 110 through the catheter 120 and into the patient. In particular embodiments, the lead delivery device 130 can be temporarily secured to the lead body 110 during delivery, as described below with reference to
The axial length of the first portion 111a can be relatively short, e.g., just long enough to support the electrodes 112 for providing the target electrical stimulation to the target neural population. The length of the first portion 111a can be less than that of conventional lead bodies so that the first portion 111a may be secured in place without being displaced by a bulky proximal portion. The isolation provided by the third portion 111c can facilitate this arrangement.
In any of the foregoing embodiments, the lead body 110 can be delivered percutaneously to the patient via a delivery device 130, as was discussed above with reference to
From the foregoing, it will be appreciated that specific embodiments of the disclosure have been described herein for purposes of illustration, but that various modifications may be made without deviating from the disclosure. For example, the lead body portions 111a-111c can have other shapes that facilitate an offset and/or relative lateral movement between the first portion 111a and the second portion 111b. Certain aspects of the disclosure described in the context of particular embodiments may be combined or eliminated in other embodiments. For example, the bayonet fitting shown in
Claims
1-33. (canceled)
34. A patient treatment device, comprising:
- a signal delivery device that includes a percutaneous portion carrying a plurality of electrodes, the signal delivery device having an aperture extending into the percutaneous portion, the aperture being coupled to a bayonet receptacle, the bayonet receptacle including a chamber and an entry positioned between the chamber and the aperture, the entry and the chamber having different cross-sectional shapes.
35. The device of claim 34 wherein the entry has a slot shape.
36. The device of claim 34 wherein the entry has a non-isodiametric shape.
37. The device of claim 34 wherein the chamber has a cylindrical shape.
38. The device of claim 34, further comprising a stylet having a bayonet fitting, the bayonet fitting having a cross-sectional shape configured to be received in the entry and the chamber of the bayonet receptacle.
39. The device of claim 38 wherein the percutaneous portion and the stylet are elongated along a deployment axis, and wherein the stylet is rotatable about the deployment axis relative to the percutaneous portion between a secured position and an unsecured position.
40. The device of claim 34 wherein the percutaneous portion includes:
- a first percutaneous portion carrying the plurality of electrodes and having a first aperture, the first portion having a first diameter;
- a second percutaneous portion spaced apart from the first portion and having a second aperture, the second portion having a second diameter; and
- a third percutaneous portion positioned between the first and second portions along a deployment axis and having a third diameter less than the first and second diameters, the third portion having a stiffness in a direction transverse to the deployment axis that is less than a stiffness of the first portion transverse to the deployment axis, and less than a stiffness of the second portion transverse to the deployment axis, the third portion including multiple electrical signal paths between the second portion and the electrodes of the first portion.
41. A neural stimulation system, comprising:
- a lead body that includes: a first percutaneous portion carrying a plurality of electrodes, the first portion having a first aperture and a bayonet receptacle, the bayonet receptacle including an entry and a chamber, the entry having a non-isodiametric shape; and a second percutaneous portion carrying a plurality of connection terminals.
42. The neural stimulation system of claim 41 wherein the first portion has a first diameter and the second portion has a second diameter, the system further comprising a third percutaneous portion having a third diameter less than the first diameter and the second diameter, the third portion including an electrical link between the electrodes and the connection terminals.
43. The neural stimulation system of claim 42 wherein the first portion, the second portion and the third portion are arranged along a deployment axis, and wherein the third portion has a stiffness in a direction transverse to the deployment axis that is less than a stiffness of the first portion transverse to the deployment axis, and less than a stiffness of the second portion transverse to the deployment axis.
44. The neural stimulation system of claim 41, further comprising a third percutaneous portion positioned between the first portion and the second portion and including a plurality of wires connected between individual electrodes and corresponding connection terminals.
45. The neural stimulation system of claim 44 wherein the third portion further includes a casing at least partially surrounding the wires.
46. The neural stimulation system of claim 41, further comprising a stylet having a bayonet fitting, the bayonet fitting having a shape corresponding to the non-isodiametric shape of the entry, and wherein the chamber comprises a cylindrical shape, the bayonet fitting rotatable within the chamber.
47. The neural stimulation system of claim 41, further comprising a stylet having a bayonet fitting, the bayonet fitting being configured to pass through the entry and rotate within the chamber.
48. A patient treatment device, comprising:
- a percutaneously implantable lead, the lead including a first portion and a second portion, wherein the first portion includes an electrode, a first aperture, and a bayonet receptacle, wherein the second portion includes a second aperture, and wherein the bayonet receptacle includes an entry and a chamber, the entry having a different cross-sectional shape than the chamber.
49. The patient treatment device of claim 48 wherein the cross-sectional shape of the entry is non-isodiametric.
50. The patient treatment device of claim 48, further comprising a stylet configured to releasably couple to the first portion, the stylet including a bayonet fitting having a cross-sectional shape corresponding to the entry.
51. The patient treatment device of claim 48, further comprising a stylet having a slot-shaped bayonet fitting, the stylet being configured to pass through the entry and rotatably couple with the first portion.
52. The patient treatment device of claim 48 wherein the second portion further includes a connection terminal, wherein the lead further comprises a third portion, and wherein the third portion includes a wire operably coupling the connection terminal to the electrode.
53. The patient treatment device of claim 48, further comprising a third portion positioned between the first portion and the second portion, the third portion having a reinforcing fiber configured to control lateral flexibility.
Type: Application
Filed: Jan 31, 2012
Publication Date: Jul 19, 2012
Applicant: Nevro Corporation (Menlo Park, CA)
Inventor: C. Lance Boling (San Jose, CA)
Application Number: 13/362,741